← Zurück zu Insidertransaktionen
Neil Kumar
Gemeldet als: Kumar Neil
Insider · Chief Executive Officer / Director
Käufe
0
0 USD
Verkäufe
23
9.831.387 USD
Unternehmen
1
mit gemeldeten Geschäften
Letzte Aktivität
17.09.2026
23 Transaktionen gesamt
| Datum | Unternehmen | Position | Art | Volumen | Preis | Stückzahl | Seit Meldung |
|---|---|---|---|---|---|---|---|
| 17.09.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 88.979,52 USD | 69,57 USD | 1.279 | – |
| 17.09.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 601.867,61 USD | 69,01 USD | 8.721 | – |
| 19.08.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 8.565,00 USD | 85,65 USD | 100 | – |
| 19.08.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 152.436,06 USD | 84,69 USD | 1.800 | – |
| 19.08.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 679.256,28 USD | 83,86 USD | 8.100 | – |
| 18.08.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 100.444,07 USD | 83,77 USD | 1.199 | – |
| 18.08.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.211.852,10 USD | 82,99 USD | 14.602 | – |
| 18.08.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.420.513,50 USD | 82,21 USD | 17.279 | – |
| 18.08.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 154.183,86 USD | 81,15 USD | 1.900 | – |
| 05.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 304.455,31 USD | 68,96 USD | 4.415 | – |
| 05.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 572.744,06 USD | 67,88 USD | 8.437 | – |
| 05.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 480.338,45 USD | 67,20 USD | 7.148 | – |
| 05.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 304.524,27 USD | 68,96 USD | 4.416 | – |
| 05.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 572.744,06 USD | 67,88 USD | 8.437 | – |
| 05.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 480.271,25 USD | 67,20 USD | 7.147 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 30.721,37 USD | 68,27 USD | 450 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.078.451,92 USD | 67,74 USD | 15.921 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 95.347,17 USD | 66,72 USD | 1.429 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 144.584,44 USD | 65,72 USD | 2.200 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 30.721,37 USD | 68,27 USD | 450 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.078.453,51 USD | 67,74 USD | 15.921 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 95.347,17 USD | 66,72 USD | 1.429 | – |
| 04.06.2026 |
Bridgebio Pharma, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 144.584,44 USD | 65,72 USD | 2.200 | – |
Alle von „Kumar Neil" gemeldeten Eigengeschäfte (Directors' Dealings) gemäß Art. 19 MAR bzw. den jeweiligen nationalen Pflichtmeldungen. Gleiche Personen können unter abweichenden Schreibweisen mehrfach geführt sein. „Seit Meldung" vergleicht den aktuellen Kurs (deutsche Handelsplätze, EUR) mit dem gemeldeten EUR-Preis der Transaktion — Meldungen in anderen Währungen bleiben ohne Angabe. Details in der Methodik.